Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction

Abstract

Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and making clinical recommendations for therapy.

Keywords

Meta-analysisMyocardial infarctionMedicineRandomized controlled trialClinical trialIntensive care medicineInternal medicine

Affiliated Institutions

Related Publications

A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts

Elliott M. Antman

Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a...

1992 JAMA 1459 citations

Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement

John P. A. Ioannidis

In response to overwhelming evidence and the consequences of poor-quality reporting of randomized, controlled trials (RCTs), many medical journals and editorial groups have now ...

2004 Annals of Internal Medicine 1506 citations

The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration

D G Altman

Overwhelming evidence now indicates that the quality of reporting of randomized, controlled trials (RCTs) is less than optimal. Recent methodologic analyses indicate that inadeq...

2001 Annals of Internal Medicine 3794 citations

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

Kenneth F. Schulz , Douglas G. Altman , David Moher

The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which ...

2010 BMC Medicine 13258 citations

The Magic of Randomization versus the Myth of Real-World Evidence

Rory Collins , Louise Bowman , Martin Landray +1 more

Nonrandomized observational analyses have been promoted as alternatives to randomized clinical trials. However, randomization ensures balance between groups, whereas nonrandomiz...

2020 New England Journal of Medicine 451 citations

Publication Info

Year: 1992
Type: article
Volume: 327
Issue: 4
Pages: 248-254
Citations: 1134
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1134

OpenAlex

Cite This

APA Style

                            
                                
                                    Joseph Lau, 
                                
                                    Elliott M. Antman, 
                                
                                    Jeanette Jimenez-Silva
                                
                                et al.
                            
                            (1992). 
                            Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction. 
                            New England Journal of Medicine
                            , 327
                            (4)
                            , 248-254.
                            https://doi.org/10.1056/nejm199207233270406
                        

Identifiers

DOI: 10.1056/nejm199207233270406